Harnessing the IL-21-BATF Pathway in the CD8+ T Cell Anti-Tumor Response is a research paper published in Cancers (2021). On theSindex it has a DataRank of 0.542. It has been cited 36 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.542
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: CA246920
National Institutes of Health
Grant: AI125741
National Institutes of Health
Grant: AI148403
American Cancer Society
Grant: Research Scholar Grant
Medical College of Wisconsin
Grant: Advancing a Healthier Wisconsin Endowment Grant
National Institute of General Medical Sciences
Grant: T32-GM080202
National Institutes of Health
Grant: 5T32GM080202-08
Medical Scientist Training Program
National Institutes of Health
Grant: 5F30CA246920-03
Reprogramming tumor-reactive CD8 T cells by targeting the IL-21-BATF pathway to treat melanoma
National Institutes of Health
Grant: 5R01AI125741-02
The Cellular and Transcriptional Control of CD8 T Cell Functional Adaptation to Chronic Viruses
National Institutes of Health
Grant: 5R01AI148403-05
Phenotypic, Functional and Transcriptional Heterogeneity in T Cell Exhaustion
FWCI
1.68
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals